Viewing Study NCT01340833

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:46 AM

Ignite Modification Date: 2026-04-13 @ 10:38 PM

Study NCT ID: NCT01340833

Status: COMPLETED

Last Update Posted: 2017-11-13

First Post: 2011-04-14

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Sponsor: GlaxoSmithKline

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module